retatrutide development status eli lilly fda approval approval: status, clinical trial results, and when it could be available π₯ Eli Lillyβs next generation
Description
doi: 10.1056/NEJMoa1504720
doi: 10.1016/j.neuropharm.2013.08.005 133 McCleanP

Fujimoto, Elizabeth Barrett-Connor, Sarah Fowler, Sam Dagogo-Jack, Reubin Andres]
Maintenance microdosing Instead of stopping completely, some people transition to a very low maintenance dose
